H.C. Wainwright Reiterates “Buy” Rating on Denali Therapeutics (DNLI) With $32 PT Following Q3 Results
Fein’s bullish stance followed Denali Therapeutics Inc. (NASDAQ:DNLI)’s Q3 results.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 3,731,695 | $54,184,211 | 0.39% | |
| 2. | Holocene Advisors Brandon Haley | 3,135,712 | $45,530,538 | +678% | 0.1% |
| 3. | Point72 Asset Management Steve Cohen | 2,519,535 | $36,583,650 | +14% | 0.06% |
| 4. | StemPoint Capital Michelle Ross | 1,734,659 | $25,187,249 | +146% | 5.05% |
| 5. | Fisher Asset Management Ken Fisher | 1,631,496 | $23,689,321 | +8% | 0.01% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 275,000 | $4,950,000.00 | 19,462,499 | 2017-12-12 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.58 | 2,937 | $39,884.46 | 242,346 | 2025-08-12 | Filing | |
| $14.64 | 806 | $11,799.84 | 216,585 | 2025-08-13 | Filing | |
| $13.58 | 2,937 | $39,884.46 | 217,391 | 2025-08-12 | Filing | |
| $15.00 | 495,282 | $7,429,230.00 | 253,071 | 2025-07-09 | Filing | |
| $20.81 | 2,907 | $60,494.67 | 175,673 | 2025-01-07 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,289,626 | $178,445,369 | 0% | |
| 2. | 11,992,918 | $174,137,169 | 0% | |
| 3. | 11,591,585 | $168,309,813 | 0.12% | |
| 4. | 6,340,316 | $92,061,393 | 0% | |
| 5. | 5,465,037 | $79,352,339 | 0.02% |